AVITA Medical RCEL
NASDAQ RCEL
$11.73 -0.23 (-1.92%)
At close: Sep 30, 2026 · 4:00 PM EDT

AVITA Medical (RCEL) Total Debt (2023 - 2026)

Updated

AVITA Medical (RCEL) recorded Total Debt of $46.66 million in Q2 2026, up 10.5% from $42.22 million a year earlier.

Analysis

AVITA Medical (RCEL) Total Debt (2023 - 2026) Analysis & Trends

At the end of FY2025, AVITA Medical reported Total Debt of $42.98 million, up 1.7% from FY2024.

  • Across earlier years, Total Debt came in at $42.25 million in FY2024 (+6.1%) and $39.81 million in FY2023.
  • The Q2 2026 figure is the highest quarterly Total Debt in data going back to Q4 2023.
  • On a year-over-year basis, Total Debt rose in five of the last six quarters, with growth averaging 3.6%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 42.55 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 32.61 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 26.56 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn -
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 28.15 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 14.94 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 12.62 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 598.70 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 16.81 Bn
10 AVITA Medical 369.89 Mn 301.56 Mn 17.77 Mn 46.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.66 Mn
Dec 31, 2025 42.98 Mn
Sep 30, 2025 42.45 Mn
Jun 30, 2025 42.22 Mn
Mar 31, 2025 41.46 Mn
Dec 31, 2024 42.25 Mn
Sep 30, 2024 42.55 Mn
Jun 30, 2024 40.99 Mn
Mar 31, 2024 41.30 Mn
Dec 31, 2023 39.81 Mn
API Access

AVITA Medical Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RCEL&period=max&api_key=YOUR_API_KEY